Literature DB >> 16547918

Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype.

Monique H M Vlak1, Richard J Sinke, Gwenda M Rabelink, Berry P H Kremer, Bart P C van de Warrenburg.   

Abstract

We report on a family with an autosomal dominant cerebellar ataxia in which we identified a novel mutation in exon 5 of the PRKCG/SCA14 gene that results in a Val138Glu substitution in the encoded protein PKCgamma. While most affected subjects displayed a late-onset uncomplicated form of spinocerebellar ataxia with occasional mild extrapyramidal features (such as postural tremor), one patient presented with a very mild nonprogressive ataxia since the age of 3 years and predominant multifocal myoclonus. (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547918     DOI: 10.1002/mds.20851

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.

Authors:  Sarah Doss; Jan Leo Rinnenthal; Tanja Schmitz-Hübsch; Alexander U Brandt; Sebastian Papazoglou; Silke Lux; Stephan Maul; Jens Würfel; Matthias Endres; Thomas Klockgether; Martina Minnerop; Friedemann Paul
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

2.  A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult.

Authors:  Katherine E Hekman; Guo-Yun Yu; Christopher D Brown; Haipeng Zhu; Xiaofei Du; Kristina Gervin; Dag Erik Undlien; April Peterson; Giovanni Stevanin; H Brent Clark; Stefan M Pulst; Thomas D Bird; Kevin P White; Christopher M Gomez
Journal:  Hum Mol Genet       Date:  2012-09-21       Impact factor: 6.150

Review 3.  Essential Tremor Within the Broader Context of Other Forms of Cerebellar Degeneration.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

4.  Effect of trehalose on the properties of mutant {gamma}PKC, which causes spinocerebellar ataxia type 14, in neuronal cell lines and cultured Purkinje cells.

Authors:  Takahiro Seki; Nana Abe-Seki; Takahiro Kikawada; Hideyuki Takahashi; Kazuhiro Yamamoto; Naoko Adachi; Shigeru Tanaka; Izumi Hide; Naoaki Saito; Norio Sakai
Journal:  J Biol Chem       Date:  2010-08-12       Impact factor: 5.157

5.  Protection from ataxia-linked apoptosis by gap junction inhibitors.

Authors:  Dingbo Lin; Dolores J Takemoto
Journal:  Biochem Biophys Res Commun       Date:  2007-08-27       Impact factor: 3.575

6.  Loss of Purkinje cells in the PKCgamma H101Y transgenic mouse.

Authors:  Yunong Zhang; Adam Snider; Lloyd Willard; Dolores J Takemoto; Dingbo Lin
Journal:  Biochem Biophys Res Commun       Date:  2008-12-03       Impact factor: 3.575

7.  Protein kinase C gamma mutations in the C1B domain cause caspase-3-linked apoptosis in lens epithelial cells through gap junctions.

Authors:  Dingbo Lin; Denton Shanks; Om Prakash; Dolores J Takemoto
Journal:  Exp Eye Res       Date:  2007-03-31       Impact factor: 3.467

8.  Spectrum and prevalence of autosomal dominant spinocerebellar ataxia in Hokkaido, the northern island of Japan: a study of 113 Japanese families.

Authors:  Rehana Basri; Ichiro Yabe; Hiroyuki Soma; Hidenao Sasaki
Journal:  J Hum Genet       Date:  2007-09-05       Impact factor: 3.172

9.  Loss of protein kinase Cgamma in knockout mice and increased retinal sensitivity to hyperbaric oxygen.

Authors:  Vladimir V Yevseyenkov; Satyabrata Das; Dingbo Lin; Lloyd Willard; Harriet Davidson; Ari Sitaramayya; Frank J Giblin; L Dang; Dolores J Takemoto
Journal:  Arch Ophthalmol       Date:  2009-04

10.  Clinical and neurophysiological profile of four German families with spinocerebellar ataxia type 14.

Authors:  Christos Ganos; Simone Zittel; Martina Minnerop; Odette Schunke; Christina Heinbokel; Christian Gerloff; Christine Zühlke; Peter Bauer; Thomas Klockgether; Alexander Münchau; Tobias Bäumer
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.